Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: pazopanib hydrochloride|PROCEDURE: pharmacological study|PROCEDURE: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)